日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Evaluation of Antibacterial Activity of Three Universal Bonding Agents Against Streptococcus mutans on Demineralized Dentin: An In Vitro Study

三种通用粘接剂对脱矿牙本质上变形链球菌抗菌活性的比较评价:一项体外研究

Rathee, Kirti; Dayal, Charu; Rani, Reena; Anukriti, A; Zia, Anjum; Sundan, Ankita; Gupta, Seema

Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma.

新型 PROTAC 靶向 FKBP12:增强骨形态发生蛋白活性和多发性骨髓瘤细胞凋亡的潜力。

Quist-Lokken Ingrid, Tilseth Mira, Andersson-Rusch Clara, Hanif Md Abu, Walz Michael, Moen Johanna Fredrikke Nordstrand, Vik Megan Anne, Slordahl Tobias Schmidt, Sundan Anders, Hausch Felix, Holien Toril

Context-Aware Retrieval-Augmented Generation for Artificial Intelligence in Urology

面向泌尿外科人工智能的上下文感知检索增强生成

Sriram, Aadhitya; N, Maheswaran; Sundan, Bose; Krishnamoorthy, Sriram

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone

羟氯喹、卡非佐米和地塞米松联合抑制蛋白酶体和自噬治疗复发/难治性多发性骨髓瘤的I期临床试验

Slørdahl, Tobias S; Askeland, Frida Bugge; Hanssen, Margrete Sofie Sætre; Hov, Håkon; Sundt-Hansen, Stine Marie; Lindahl, Sofia; Vethe, Nils Tore; Hjorth-Hansen, Henrik; Fenstad, Mona H; Waage, Anders; Hjertner, Øyvind; Schjesvold, Fredrik; Sundan, Anders

FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells

FKBP12 是多发性骨髓瘤细胞中 ALK2 活性的主要调节剂

Ingrid Quist-Løkken, Clara Andersson-Rusch, Martin Haugrud Kastnes, Jürgen Markus Kolos, Jerome Jatzlau, Hanne Hella, Oddrun Elise Olsen, Anders Sundan, Petra Knaus, Felix Hausch, Toril Holien

Development and Content Validation of the Swimming Competence Assessment Scale (SCAS): A Modified Delphi Study

游泳能力评估量表(SCAS)的开发和内容验证:一项改进的德尔菲研究

Sundan, Jon; Haga, Monika; Lorås, Håvard

Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence

多发性骨髓瘤治疗压力后的克隆进化:异质性基因组畸变和转录组趋同

Kristine Misund #, Davine Hofste Op Bruinink #, Eivind Coward, Remco M Hoogenboezem, Even Holth Rustad, Mathijs A Sanders, Morten Rye, Anne-Marit Sponaas, Bronno van der Holt, Sonja Zweegman, Eivind Hovig, Leonardo A Meza-Zepeda, Anders Sundan, Ola Myklebost, Pieter Sonneveld #, Anders Waage #6

Preparation and optimization of medicated cold cream using Caralluma adscendens var. attenuata for the treatment of Candida skin infection

利用卡拉鲁马树(Caralluma adscendens var. attenuata)制备和优化用于治疗念珠菌皮肤感染的药用冷霜

Sundar, Madasamy; Suresh, Sundan; Lingakumar, Krishnasamy

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

旁观者记忆T细胞与IMiD/检查点疗法在多发性骨髓瘤中的应用:一场危险的探戈?

Sponaas, Anne Marit; Waage, Anders; Vandsemb, Esten N; Misund, Kristine; Børset, Magne; Sundan, Anders; Slørdahl, Tobias Schmidt; Standal, Therese

Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells

细胞内IL-32调节恶性浆细胞的线粒体代谢、增殖和分化。

Kristin Roseth Aass ,Robin Mjelle ,Martin H Kastnes ,Synne S Tryggestad ,Luca M van den Brink ,Ingrid Aass Roseth ,Marita Westhrin ,Muhammad Zahoor ,Siv H Moen ,Tonje M Vikene Nedal ,Glenn Buene ,Kristine Misund ,Anne-Marit Sponaas ,Qianli Ma ,Anders Sundan ,Richard Wj Groen ,Tobias S Slørdahl ,Anders Waage ,Therese Standal